From Lab to Bedside: How Newark's Prion Disease Research Is Reshaping the Path to Treatment
Prion disease research has accelerated significantly in recent years, with novel therapeutic strategies moving from preclinical investigation into early-phase human trials. Newark CJD Center sits at the forefront of this progress, contributing to a growing body of science that is beginning to offer concrete hope where once there was very little.